Eli Lilly And Co  

(Public, FRA:LLY)   Watch this stock  
Find more results for LLY
-0.08 (-0.11%)
Real-time:   3:25PM GMT+1
FRA real-time data - Disclaimer
Currency in EUR
Range 77.96 - 78.80
52 week 59.00 - 78.86
Open 77.96
Vol. 424.00
Mkt cap     -
P/E     -
Div/yield     -
EPS     -
Shares 1.00
Beta     -
Inst. own     -
Jan 31, 2017
Q4 2016 Eli Lilly and Co Earnings Release
Jan 31, 2017
Q4 2016 Eli Lilly and Co Earnings Call
Jan 11, 2017
Eli Lilly and Co at JPMorgan Healthcare Conference
Dec 15, 2016
Eli Lilly and Co 2017 Financial Guidance Call - Webcast


Lilly Corporate Ctr, Drop Code 1112
United States - Map
+1-317-2762000 (Phone)
+1-317-2763492 (Fax)

Website links

External links


Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company's Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, such as Humalog and Humalog Mix 75/25; neuroscience products, such as Cymbalta and Zyprexa; oncology products, such as Alimta and Cyramza, and cardiovascular products, such as Cialis and ReoPro. The Company's animal health products segment includes products for food animals, such as Rumensin and Posilac; products for companion animals, such as Onsior and Osurnia, and Novartis Animal Health (Novartis AH) products.

Officers and directors

John C. Lechleiter Ph.D. Chairman of the Board
Age: 62
David A. Ricks Chairman of the Board, President, Chief Executive Officer
Age: 48
Derica W. Rice Chief Financial Officer, Executive Vice President - Global Services
Age: 51
Maria A. Crowe President - Manufacturing Operations
Age: 56
Jan M. Lundberg Ph.D. Executive Vice President - Science and Technology, President - Lilly Research Laboratories
Age: 62
Melissa S. Barnes Senior Vice President - Enterprise Risk Management and Chief Ethics and Compliance Officer
Age: 48
Michael J. Harrington Senior Vice President, General Counsel
Age: 53
Stephen F. Fry Senior Vice President - Human Resources and Diversity
Age: 50
Enrique A. Conterno Senior Vice President and President - Lilly Diabetes
Age: 49
Susan Mahony Ph.D. Senior Vice President and President - Lilly Oncology
Age: 51